FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2025
Voltar para busca
Dado oficial do USPTO
OMERO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
OMERO
ST13
US500000079315257Classe
9, 35, 42, 45
Pedido
79315257
Registro
7497630
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
10/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 42, 45
Data de depósito
09/03/2021
Data de registro
10/09/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/09/2024
Última transação
10/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Seattle, WA
Examinador
MONINGHOFF, KIM
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Glencoe Software Inc.
Representantes
STACEY J. WATSON, ESQ. MARKERY LAW LLC
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Computer software that is downloaded and installed for use in connection with the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; computer software downloadable from the Internet for use in connection with the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science;data access and data management software tools that are downloaded and installed for use in connection with the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; downloadable electronic publications in the nature of scientific journalsperiodicals and newsletters relating to the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; none of the foregoing for use by clinical care providersfuture or current patientstheir families in connection with pharmaceuticalsbiopharmaceuticals or therapeutic methodsproduceddesignedmarketed for providing medical and scientific research summariesreportsopinions regarding the efficacysafetypharmacological characteristicsother properties of pharmaceutical and biopharmaceutical productsproduct candidatesdevelopment programstherapeutic methodsdrug delivery systemsmedical treatmentsdiagnostic methodsrelating to a specific diseasedisordercategory thereof
Classe 35
Business services relating to the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical sciencemanagement of biological and biomedical data and images for business enterprises; data processing services relating to the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; informationadvisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providersfuture or current patientstheir families in connection with pharmaceuticalsbiopharmaceuticals or therapeutic methodsproduceddesignedmarketed for providing medical and scientific research summariesreportsopinions regarding the efficacysafetypharmacological characteristicsother properties of pharmaceutical and biopharmaceutical productsproduct candidatesdevelopment programstherapeutic methodsdrug delivery systemsmedical treatmentsdiagnostic methodsrelating to a specific diseasedisordercategory thereof
Classe 42
Design and development of computer softwaredata access and data management software tools for use in connection with the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; computer programming; installationmaintenance and repair of computer software; design of computer websites and maintenance thereofall relating to the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; software as a service (SAAS) featuring software for accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; informationadvisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providersfuture or current patientstheir families in connection with pharmaceuticalsbiopharmaceuticals or therapeutic methodsproduceddesignedmarketed for providing medical and scientific research summariesreportsopinions regarding the efficacysafetypharmacological characteristicsother properties of pharmaceutical and biopharmaceutical productsproduct candidatesdevelopment programstherapeutic methodsdrug delivery systemsmedical treatmentsdiagnostic methodsrelating to a specific diseasedisordercategory thereof
Classe 45
Licensing of computer software for use in connection with the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; informationadvisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providersfuture or current patientstheir families in connection with pharmaceuticalsbiopharmaceuticals or therapeutic methodsproduceddesignedmarketed for providing medical and scientific research summariesreportsopinions regarding the efficacysafetypharmacological characteristicsother properties of pharmaceutical and biopharmaceutical productsproduct candidatesdevelopment programstherapeutic methodsdrug delivery systemsmedical treatmentsdiagnostic methodsrelating to a specific diseasedisordercategory thereof
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/04/2025
FIMP
FINAL DISPOSITION PROCESSED
18/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/09/2024
TMBN
TTAB RELEASE CASE TO TRADEMARKS
02/08/2024
OP.T
OPPOSITION TERMINATED NO. 999999
02/08/2024
OP.D
OPPOSITION DISMISSED NO. 999999
02/08/2024
RFNT
REFUSAL PROCESSED BY IB
30/05/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
03/05/2023
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
01/05/2023
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
29/04/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/12/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
14/12/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
14/11/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/11/2022
PUBO
PUBLISHED FOR OPPOSITION
01/11/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/10/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/09/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/09/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/05/2022
GNFR
FINAL REFUSAL E-MAILED
11/05/2022
CNFR
FINAL REFUSAL WRITTEN
11/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/05/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/05/2022
RFNT
REFUSAL PROCESSED BY IB
29/11/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/11/2021
RFRR
REFUSAL PROCESSED BY MPU
08/11/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/10/2021
CNRT
NON-FINAL ACTION WRITTEN
07/10/2021
DOCK
ASSIGNED TO EXAMINER
04/10/2021
MAFR
APPLICATION FILING RECEIPT MAILED
30/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/07/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
19/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OMERO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.